28
FEB
Reports
Q4, 2023 earnings report expected
CLDX
Celldex Therapeutics Inc
40.80
-0.35
(-0.85%)
EPS
$-0.788571
Estimated Sales
$931.67K
Market Cap
$1.54B
Trade
Mentioned
CLDX
-0.44 (-1.07%)
S
40.88
B
41.09
@MarketUpdates
United Kingdom10 months ago
28
FEB
Reports
Q4, 2023 earnings report expected
CLDX
Celldex Therapeutics Inc
40.80
-0.35
(-0.85%)
EPS
$-0.788571
Estimated Sales
$931.67K
Market Cap
$1.54B
Trade
1 Mentioned
CLDX
Celldex Therapeutics Inc